CG Oncology, Stock Forecast - Daily Balance Of Power
| CGON Stock | 34.75 0.65 1.91% |
CGON Stock Forecast is based on your current time horizon. Although CG Oncology,'s naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of CG Oncology,'s systematic risk associated with finding meaningful patterns of CG Oncology, fundamentals over time.
CGON |
| Previous Daily Balance Of Power | Daily Balance Of Power | Trend |
| 0.0958 | (0.54) |
| Check CG Oncology, Volatility | Backtest CG Oncology, | Trend Details |
CG Oncology, Trading Date Momentum
| On June 21 2024 CG Oncology, Common was traded for 31.43 at the closing time. The top price for the day was 32.86 and the lowest listed price was 31.04 . The trading volume for the day was 1.9 M. The trading history from June 21, 2024 was a factor to the next trading day price decrease. The overall trading delta against the next closing price was 2.12% . The overall trading delta against the current closing price is 0.87% . |
Balance of Power indicator was created by Igor Livshin to predict asset short term price movements or warning signals. If Balance of Power indicator is trended towards the high of its range it will signify that the bulls are in control. On the other hand when the BOP indicator is moving towards the lows of its range it signifies that the bears are in control. If the indicator move from a high positive range to a lower positive range it signifies that the buying pressure is decreasing. Conversely, if the indicator move from a low negative range to a higher negative range it signifies that the selling pressure is decreasing.
| Compare CG Oncology, to competition |
Other Forecasting Options for CG Oncology,
For every potential investor in CGON, whether a beginner or expert, CG Oncology,'s price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. CGON Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in CGON. Basic forecasting techniques help filter out the noise by identifying CG Oncology,'s price trends.CG Oncology, Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with CG Oncology, stock to make a market-neutral strategy. Peer analysis of CG Oncology, could also be used in its relative valuation, which is a method of valuing CG Oncology, by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
CG Oncology, Common Technical and Predictive Analytics
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of CG Oncology,'s price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of CG Oncology,'s current price.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
CG Oncology, Market Strength Events
Market strength indicators help investors to evaluate how CG Oncology, stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading CG Oncology, shares will generate the highest return on investment. By undertsting and applying CG Oncology, stock market strength indicators, traders can identify CG Oncology, Common entry and exit signals to maximize returns.
CG Oncology, Risk Indicators
The analysis of CG Oncology,'s basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in CG Oncology,'s investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting cgon stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 2.05 | |||
| Standard Deviation | 2.74 | |||
| Variance | 7.53 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Pair Trading with CG Oncology,
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if CG Oncology, position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CG Oncology, will appreciate offsetting losses from the drop in the long position's value.Moving against CGON Stock
| 0.45 | BMY | Bristol Myers Squibb Sell-off Trend | PairCorr |
| 0.43 | ESPR | Esperion Therapeutics Buyout Trend | PairCorr |
| 0.39 | VTRS | Viatris | PairCorr |
| 0.32 | BFRIW | Biofrontera Warrants | PairCorr |
The ability to find closely correlated positions to CG Oncology, could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace CG Oncology, when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back CG Oncology, - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling CG Oncology, Common to buy it.
The correlation of CG Oncology, is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as CG Oncology, moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if CG Oncology, Common moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for CG Oncology, can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Historical Fundamental Analysis of CG Oncology, to cross-verify your projections. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of CG Oncology,. If investors know CGON will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about CG Oncology, listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (15.87) | Revenue Per Share 0.015 | Quarterly Revenue Growth 3.778 | Return On Assets (0.16) | Return On Equity (0.20) |
The market value of CG Oncology, Common is measured differently than its book value, which is the value of CGON that is recorded on the company's balance sheet. Investors also form their own opinion of CG Oncology,'s value that differs from its market value or its book value, called intrinsic value, which is CG Oncology,'s true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because CG Oncology,'s market value can be influenced by many factors that don't directly affect CG Oncology,'s underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between CG Oncology,'s value and its price as these two are different measures arrived at by different means. Investors typically determine if CG Oncology, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, CG Oncology,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.